Title : Bioequivalence of different dose-strength tablets of selexipag, a selective prostacyclin receptor agonist, in a multiple-dose up-titration study.

Pub. Date : 2015 Sep

PMID : 26152132






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bioequivalence of different dose-strength tablets of selexipag, a selective prostacyclin receptor agonist, in a multiple-dose up-titration study. selexipag prostaglandin I2 receptor Homo sapiens
2 OBJECTIVE: Selexipag is a novel, oral, selective prostacyclin (PGI2) receptor agonist in clinical development for the treatment of pulmonary arterial hypertension. selexipag prostaglandin I2 receptor Homo sapiens